Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3).
Clark MP, George KM, Bookland RG, Chen J, Laughlin SK, Thakur KD, Lee W, Davis JR, Cabrera EJ, Brugel TA, VanRens JC, Laufersweiler MJ, Maier JA, Sabat MP, Golebiowski A, Easwaran V, Webster ME, De B, Zhang G.
Clark MP, et al. Among authors: george km.
Bioorg Med Chem Lett. 2007 Mar 1;17(5):1250-3. doi: 10.1016/j.bmcl.2006.12.018. Epub 2006 Dec 9.
Bioorg Med Chem Lett. 2007.
PMID: 17189692